Annual Lung SPORE Workshop (Abstract Submission): Submission #10

Submission information
Submission Number: 10
Submission ID: 110371
Submission UUID: 7e633443-a6ca-4268-b138-1d82ec367fe5

Created: Fri, 03/08/2024 - 18:05
Completed: Fri, 03/08/2024 - 18:16
Changed: Wed, 05/29/2024 - 17:10

Remote IP address: 10.208.28.228
Submitted by: Anonymous
Language: English

Is draft: No
First Name Monique (Presented by Heymach)
Last Name Nilsson
Email mnilsson@mdanderson.org
Phone 7137458407
Affiliation - Presenter MD Anderson Cancer Center - John Heymach
Abstract Title Trastuzumab deruxtecan resistance can be mediated by payload resistance or secondary extracellular ERBB2 mutations but sensitivity to HER2 tyrosine kinase inhibitors is maintained
First Author First Name John
First Author Last Name Heymach (Submitted by M. Nilsson)
Affiliation MD Anderson Cancer Center
List of Additional Authors
  • First Name: Xiuning
    Last Name: Le
    Affiliation: MDACC
  • First Name: Junqin
    Last Name: He
    Affiliation: MDACC
  • First Name: Xiaoxing
    Last Name: Yu
    Affiliation: MDACC
  • First Name: Xiaofang
    Last Name: Huo
    Affiliation: UTSW
  • First Name: Ashwani
    Last Name: Kumar
    Affiliation: UTSW
  • First Name: Alissa
    Last Name: Poteete
    Affiliation: MDACC
  • First Name: Qian
    Last Name: Huang
    Affiliation: MDACC
  • First Name: Ralf
    Last Name: Kittler
    Affiliation: UTSW
  • First Name: John
    Last Name: Heymach
    Affiliation: MDACC
Select a Session Topic Session 1: Oncogene-driven lung cancers and resistance to targeted therapies
Your Abstract Submission Abstract_Submission.pdf
Upload Abstract
Special Characters Included? No
Abstract Review Status
Poster Uploaded
Upload Poster 2024.5.29 Heymach Lung Spore Enhertu Resistance.jpg